NOT FOR DISTRIBUTION
Header cover image

Market Cap

CA$42.2m

Last Updated

2021/05/12 22:32 UTC

Data Sources

Company Financials +

Executive Summary

Newtopia Inc., a health technology company, operates a habit change platform. More Details


Snowflake Analysis

Adequate balance sheet and slightly overvalued.


Similar Companies

Share Price & News

How has Newtopia's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: NEWU is more volatile than 75% of Canadian stocks over the past 3 months, typically moving +/- 15% a week.

Volatility Over Time: NEWU's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of Canadian stocks.


Market Performance


7 Day Return

-5.5%

NEWU

-4.2%

CA Healthcare Services

-0.8%

CA Market


1 Year Return

-15.7%

NEWU

106.7%

CA Healthcare Services

38.7%

CA Market

Return vs Industry: NEWU underperformed the Canadian Healthcare Services industry which returned 105.2% over the past year.

Return vs Market: NEWU underperformed the Canadian Market which returned 36.3% over the past year.


Shareholder returns

NEWUIndustryMarket
7 Day-5.5%-4.2%-0.8%
30 Day-20.4%-11.9%0.2%
90 Day-24.6%-10.7%5.5%
1 Year-15.7%-15.7%106.7%106.7%43.3%38.7%
3 Yearn/a-51.0%-51.0%27.3%15.2%
5 Yearn/a-72.3%-72.3%57.2%33.6%

Long-Term Price Volatility Vs. Market

How volatile is Newtopia's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Newtopia undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: NEWU (CA$0.43) is trading below our estimate of fair value (CA$1.32)

Significantly Below Fair Value: NEWU is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: NEWU is unprofitable, so we can't compare its PE Ratio to the North American Healthcare Services industry average.

PE vs Market: NEWU is unprofitable, so we can't compare its PE Ratio to the Canadian market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate NEWU's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: NEWU is overvalued based on its PB Ratio (10.2x) compared to the CA Healthcare Services industry average (8.3x).


Future Growth

How is Newtopia forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?

18.7%

Forecasted annual revenue growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if NEWU's forecast earnings growth is above the savings rate (1.5%).

Earnings vs Market: Insufficient data to determine if NEWU's earnings are forecast to grow faster than the Canadian market

High Growth Earnings: Insufficient data to determine if earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: NEWU's revenue (18.7% per year) is forecast to grow faster than the Canadian market (6.5% per year).

High Growth Revenue: NEWU's revenue (18.7% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if NEWU's Return on Equity is forecast to be high in 3 years time


Past Performance

How has Newtopia performed over the past 5 years?

23.7%

Last years earnings growth


Earnings and Revenue History

Quality Earnings: NEWU is currently unprofitable.

Growing Profit Margin: NEWU is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if NEWU's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Unable to compare NEWU's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: NEWU is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (18.1%).


Return on Equity

High ROE: NEWU has a negative Return on Equity (-184.1%), as it is currently unprofitable.


Financial Health

How is Newtopia's financial position?


Financial Position Analysis

Short Term Liabilities: NEWU's short term assets (CA$7.1M) exceed its short term liabilities (CA$3.0M).

Long Term Liabilities: NEWU's short term assets (CA$7.1M) exceed its long term liabilities (CA$667.6K).


Debt to Equity History and Analysis

Debt Level: NEWU is debt free.

Reducing Debt: NEWU had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: NEWU has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if NEWU has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Dividend

What is Newtopia current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate NEWU's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate NEWU's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if NEWU's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if NEWU's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of NEWU's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

0.5yrs

Average management tenure


CEO

Jeff Ruby

no data

Tenure

CA$300,000

Compensation

Mr. Jeffrey Ruby, also known as Jeff, J.D., MBA serves as Director at Newtopia Inc. since May 27, 2020. Mr. Ruby is the Founder and Chief Executive Officer of Newtopia Inc. Mr. Ruby is a health innovator w...


CEO Compensation Analysis

Compensation vs Market: Jeff's total compensation ($USD248.00K) is above average for companies of similar size in the Canadian market ($USD156.15K).

Compensation vs Earnings: Insufficient data to compare Jeff's compensation with company performance.


Leadership Team

Experienced Management: NEWU's management team is not considered experienced ( 0.5 years average tenure), which suggests a new team.


Board Members

Experienced Board: NEWU's board of directors are not considered experienced ( 1 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 10.8%.


Top Shareholders

Company Information

Newtopia Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Newtopia Inc.
  • Ticker: NEWU
  • Exchange: TSXV
  • Founded: 2008
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: CA$42.207m
  • Shares outstanding: 100.49m
  • Website: https://www.newtopia.com

Number of Employees


Location

  • Newtopia Inc.
  • 4101 Yonge Street
  • Suite 706
  • Toronto
  • Ontario
  • M2P 1N6
  • Canada

Listings


Biography

Newtopia Inc., a health technology company, operates a habit change platform. It offers a personalized habit change platform that focuses on metabolic risk reduction by developing and implementing personal...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/05/12 22:32
End of Day Share Price2021/05/12 00:00
Earnings2020/12/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.